|
1
|
Molitch ME: Diagnosis and treatment of
pituitary adenomas: A review. JAMA. 317:516–524. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lefevre E, Chasseloup F, Hage M, Chanson
P, Buchfelder M and Kamenický P: Clinical and therapeutic
implications of cavernous sinus invasion in pituitary adenomas.
Endocrine. 85:1058–1065. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lu L, Wan X, Xu Y, Chen J, Shu K and Lei
T: Prognostic factors for recurrence in pituitary adenomas: Recent
progress and future directions. Diagnostics (Basel). 12:9772022.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen L, White WL, Spetzler RF and Xu B: A
prospective study of nonfunctioning pituitary adenomas:
Presentation, management, and clinical outcome. J Neurooncol.
102:129–138. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Raverot G, Ilie MD, Lasolle H, Amodru V,
Trouillas J, Castinetti F and Brue T: Aggressive pituitary tumours
and pituitary carcinomas. Nat Rev Endocrinol. 17:671–684. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
James EL and Parkinson EK: Serum
metabolomics in animal models and human disease. Curr Opin Clin
Nutr Metabolic Care. 18:478–483. 2015.PubMed/NCBI
|
|
7
|
Kwon YW, Jo HS, Bae S, Seo Y, Song P, Song
M and Yoon JH: Application of proteomics in cancer: Recent trends
and approaches for biomarkers discovery. Front Med. 8:7473332021.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Knosp E, Steiner E, Kitz K and Matula C:
Pituitary adenomas with invasion of the cavernous sinus space: A
magnetic resonance imaging classification compared with surgical
findings. Neurosurgery. 33:610–617. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cox J, Hein MY, Luber CA, Paron I, Nagaraj
N and Mann M: Accurate proteome-wide label-free quantification by
delayed normalization and maximal peptide ratio extraction, termed
MaxLFQ. Mol Cell Proteomics. 13:2513–2526. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Smyth GK: Linear models and empirical
bayes methods for assessing differential expression in microarray
experiments. Stat Appl Genet Mol Biol. 3:1–25. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Szklarczyk D, Kirsch R, Koutrouli M,
Nastou K, Mehryary F, Hachilif R, Gable AL, Fang T, Doncheva NT,
Pyysalo S, et al: The STRING database in 2023: Protein-protein
association networks and functional enrichment analyses for any
sequenced genome of interest. Nucleic Acids Res. 51:D638–D646.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Casado-Vela J, Cebrián A, del Pulgar MT
and Lacal JC: Approaches for the study of cancer: Towards the
integration of genomics, proteomics and metabolomics. Clin Transl
Oncol. 13:617–628. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sassone-Corsi P: The cyclic AMP pathway.
Cold Spring Harb Perspect Biol. 4:a0111482012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Steven A, Friedrich M, Jank P, Heimer N,
Budczies J, Denkert C and Seliger B: What turns CREB on? And off?
And why does it matter? Cell Mol Life Sci. 77:4049–4067. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Häfner S, Adler HS, Mischak H, Janosch P,
Heidecker G, Wolfman A, Pippig S, Lohse M, Ueffing M and Kolch W:
Mechanism of inhibition of raf-1 by protein kinase a. Mo Cell Biol.
14:6696–6703. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jensen J, Brennesvik EO, Lai YC and
Shepherd PR: GSK-3beta regulation in skeletal muscles by adrenaline
and insulin: Evidence that PKA and PKB regulate different pools of
GSK-3. Cell Signal. 19:204–210. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang M, Li Y, Wang R, Wang Z, Chen K, Zhou
B, Zhou Z and Sun X: PKA RIα/a-kinase anchoring proteins 10
signaling pathway and the prognosis of colorectal cancer. J
Gastroenterol Hepatol. 30:496–503. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Finger EC, Castellini L, Rankin EB,
Vilalta M, Krieg AJ, Jiang D, Banh A, Zundel W, Powell MB and
Giaccia AJ: Hypoxic induction of AKAP12 variant 2 shifts
PKA-mediated protein phosphorylation to enhance migration and
metastasis of melanoma cells. Proc Natl Acad Sci USA.
112:4441–4446. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shaikh D, Zhou Q, Chen T, Ibe JCF, Raj JU
and Zhou G: cAMP-dependent protein kinase is essential for
hypoxia-mediated epithelial-mesenchymal transition, migration, and
invasion in lung cancer cells. Cell Signal. 24:2396–2406. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tonucci FM, Almada E, Borini-Etichetti C,
Pariani A, Hidalgo F, Rico MJ, Girardini J, Favre C, Goldenring JR,
Menacho-Marquez M and Larocca MC: Identification of a CIP4 PKA
phosphorylation site involved in the regulation of cancer cell
invasiveness and metastasis. Cancer Lett. 461:65–77. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
McKenzie AJ, Campbell SL and Howe AK:
Protein kinase A activity and anchoring are required for ovarian
cancer cell migration and invasion. PLoS One. 6:e265522011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bizzi MF, Bolger GB, Korbonits M and
Ribeiro-Oliveira Jr: Phosphodiesterases and cAMP pathway in
pituitary diseases. Front Endocrinol (Lausanne). 10:1412019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lania A, Mantovani G and Spada A: cAMP
pathway and pituitary tumorigenesis. Ann Endocrinol (Paris).
73:73–75. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pertuit M, Barlier A, Enjalbert A and
Gérard C: Signalling pathway alterations in pituitary adenomas:
Involvement of gsα, cAMP and mitogen-activated protein kinases. J
Neuroendocrinol. 21:869–877. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Singh AP, Sharma S, Pagarware K, Siraji
RA, Ansari I, Mandal A, Walling P and Aijaz S: Enteropathogenic E.
coli effectors EspF and Map independently disrupt tight junctions
through distinct mechanisms involving transcriptional and
post-transcriptional regulation. Sci Rep. 8:37192018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Croxen MA and Finlay BB: Molecular
mechanisms of escherichia coli pathogenicity. Nat Rev Microbiol.
8:26–38. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li X and Wang J: Mechanical tumor
microenvironment and transduction: Cytoskeleton mediates cancer
cell invasion and metastasis. Int J Biol Sci. 16:2014–2028. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Aseervatham J: Cytoskeletal remodeling in
cancer. Biology (Basel). 9:3852020.PubMed/NCBI
|
|
29
|
Nejman D, Livyatan I, Fuks G, Gavert N,
Zwang Y, Geller LT, Rotter-Maskowitz A, Weiser R, Mallel G, Gigi E,
et al: The human tumor microbiome is composed of tumor
type-specific intracellular bacteria. Science. 368:973–980. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Niño JL, Wu H, LaCourse KD, Kempchinsky
AG, Baryiames A, Barber B, Futran N, Houlton J, Sather C, Sicinska
E, et al: Effect of the intratumoral microbiota on spatial and
cellular heterogeneity in cancer. Nature. 611:810–817. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kalaora S, Nagler A, Nejman D, Alon M,
Barbolin C, Barnea E, Ketelaars SLC, Cheng K, Vervier K, Shental N,
et al: Identification of bacteria-derived HLA-bound peptides in
melanoma. Nature. 592:138–143. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hu J, Yang J, Chen L, Meng X, Zhang X, Li
W, Li Z and Huang G: Alterations of the gut microbiome in patients
with pituitary adenoma. Pathol Oncol Res. 28:16104022022.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nie D, Li C and Zhang Y: PitNETs and the
gut microbiota: Potential connections, future directions. Front
Endocrinol (Lausanne). 14:12559112023. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Südhof TC: The synaptic vesicle cycle. Ann
Rev Neurosci. 27:509–547. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chanaday NL, Cousin MA, Milosevic I,
Watanabe S and Morgan JR: The synaptic vesicle cycle revisited: New
insights into the modes and mechanisms. J Neurosci. 39:8209–8216.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rizo J and Südhof TC: The membrane fusion
enigma: SNAREs, Sec1/Munc18 proteins, and their accomplices-guilty
as charged? Annu Rev Cell Dev Biol. 28:279–308. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sheng B, Jiang Y, Wu D, Lai N, Ye Z, Zhang
B, Fang X and Xu S: RNAi-mediated SYT14 knockdown inhibits the
growth of human glioma cell line U87MG. Brain Res Bull. 140:60–64.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Taylor KR, Barron T, Hui A, Spitzer A,
Yalçin B, Ivec AE, Geraghty AC, Hartmann GG, Arzt M, Gillespie SM,
et al: Glioma synapses recruit mechanisms of adaptive plasticity.
Nature. 623:366–374. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Venkatesh HS, Morishita W, Geraghty AC,
Silverbush D, Gillespie SM, Arzt M, Tam LT, Espenel C, Ponnuswami
A, Ni L, et al: Electrical and synaptic integration of glioma into
neural circuits. Nature. 573:539–545. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Venkataramani V, Tanev DI, Strahle C,
Studier-Fischer A, Fankhauser L, Kessler T, Körber C, Kardorff M,
Ratliff M, Xie R, et al: Glutamatergic synaptic input to glioma
cells drives brain tumour progression. Nature. 573:532–538. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Winkler F, Venkatesh HS, Amit M, Batchelor
T, Demir IE, Deneen B, Gutmann DH, Hervey-Jumper S, Kuner T,
Mabbott D, et al: Cancer neuroscience: State of the field, emerging
directions. Cell. 186:1689–1707. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Greengard P, Valtorta F, Czernik AJ and
Benfenati F: Synaptic vesicle phosphoproteins and regulation of
synaptic function. Science. 259:780–785. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Baba T, Sakisaka T, Mochida S and Takai Y:
PKA-catalyzed phosphorylation of tomosyn and its implication in
Ca2+-dependent exocytosis of neurotransmitter. J Cell Biol.
170:1113–1125. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chheda MG, Ashery U, Thakur P, Rettig J
and Sheng ZH: Phosphorylation of Snapin by PKA modulates its
interaction with the SNARE complex. Nat Cell Biol. 3:331–338. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Clementi F, Fesce R, Meldolesi J, Valtorta
F, Hilfiker S, Pieribone VA, Czernik AJ, Kao HT, Augustine GJ and
Greengard P: Synapsins as regulators of neurotransmitter release.
Philosophical Transactions of the Royal Society of London Series B:
Biological Sciences. 354:269–279. 1999. View Article : Google Scholar
|
|
46
|
Raja SA, Abbas S, Shah STA, Tariq A, Bibi
N, Yousuf A, Khawaja A, Nawaz M, Mehmood A, Khan MJ and Hussain A:
Increased expression levels of Syntaxin 1A and Synaptobrevin
2/vesicle-associated membrane protein-2 are associated with the
progression of bladder cancer. Genet Mol Biol. 42:40–47. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hasan N and Hu C: Vesicle-associated
membrane protein 2 mediates trafficking of alpha5beta1 integrin to
the plasma membrane. Exp Cell Res. 316:12–23. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Trisciuoglio D and Degrassi F: The tubulin
code and tubulin-modifying enzymes in autophagy and cancer. Cancers
(Basel). 14:62021. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Peters A, Rabe P, Krumbholz P, Kalwa H,
Kraft R, Schöneberg T and Stäubert C: Natural biased signaling of
hydroxycarboxylic acid receptor 3 and G protein-coupled receptor
84. Cell Commun Signal. 18:312020. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Cho-Chung YS and Nesterova MV: Tumor
reversion: Protein kinase A isozyme switching. Ann N Y Acad Sci.
1058:76–86. 2005. View Article : Google Scholar : PubMed/NCBI
|
